Advertisement

Diabetologia

, Volume 57, Issue 10, pp 2232–2234 | Cite as

An explanation for recent discrepancies in levels of human circulating betatrophin

  • Zhiyao Fu
  • Abdul B. Abou-Samra
  • Ren Zhang
Letter

Keywords

ANGPTL8 Betatrophin C19orf80 Lipasin RIFL 

Abbreviations

ANGPTL

Angiopoietin-like protein

LPL

Lipoprotein lipase

Notes

Note added in proof

Consistent with the result of negative correlation between betatrophin and BMI based on the N-terminal kit (Fig. 1c), in a recent study, Gómez-Ambrosi et al [11] showed that circulating betatrophin is decreased in obesity.

Funding

This work was supported by a startup fund from Wayne State University to RZ.

Duality of interest

The authors confirm that there is no duality of interest associated with this manuscript.

Contribution statement

ZF performed the experiments, analysed the data and participated in manuscript revision. ABA-S participated in data analysis and manuscript revision. RZ designed the study, analysed the data and wrote the manuscript. All authors have approved the final version. RZ is the guarantor of this work.

References

  1. 1.
    Zhang R (2012) Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 424:786–792PubMedCrossRefGoogle Scholar
  2. 2.
    Ren G, Kim JY, Smas CM (2012) Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 303:E334–E351PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Quagliarini F, Wang Y, Kozlitina J et al (2012) Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A 109:19751–19756PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Wang Y, Quagliarini F, Gusarova V et al (2013) Mice lacking ANGPTL8 (betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 110:16109–16114PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Yi P, Park JS, Melton DA (2013) Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153:747–758PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Espes D, Lau J, Carlsson PO (2014) Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 57:50–53PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Fenzl A, Itariu BK, Kosi L et al (2014) Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 57:1204–1208PubMedCrossRefGoogle Scholar
  8. 8.
    Espes D, Martinell M, Carlsson PO (2014) Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014:323407PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R (2014) Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 4:5013PubMedGoogle Scholar
  10. 10.
    Chang JK, Lyu RM, Chen XQ et al (2013) Detection of C-terminal betatrophin peptides in human plasma and rodent liver. In: Nishiuchi Y, Teshima T (eds) The 4th Asia-Pacific International Peptide Symposium. Peptide Science, Japan, pp 243–246Google Scholar
  11. 11.
    Gómez-Ambrosi J, Pascual E, Catalán V et al (2014) Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Center for Molecular Medicine and Genetics, School of MedicineWayne State UniversityDetroitUSA
  2. 2.Department of MedicineHamad Medical CorporationDohaQatar

Personalised recommendations